摘要
根据GenBank中已发表的H5亚型禽流感病毒HA基因序列 ,设计一对引物 ,通过RT PCR扩增鹅源H5亚型高致病力禽流感病毒HA基因 ,测序确认后 ,将其克隆入真核表达载体pVAX1和asd pVAX1得到重组表达载体pVAX1 HA和asd pVAX1 HA。将重组质粒转染P815细胞 ,经间接免疫荧光试验证实 ,HA基因在细胞内得到了瞬时表达。进一步将重组质粒转化减毒鼠伤寒沙门氏菌X4 5 5 0得到两种运送DNA疫苗的重组沙门氏菌X4 5 5 0 (pVAX1 HA)和X4 5 5 0 (asd pVAX1 HA) ,以 1× 10 9CFU 只的剂量两次口服免疫BALB c小鼠 ,免疫小鼠不仅可以检测到HA特异性的血清抗体应答 ,而且还能抵抗稳定表达H5亚型禽流感病毒HA基因的P815肥大细胞瘤的攻击 ,说明该运送DNA疫苗的减毒沙门氏菌系统在体内能够成功释放所携带的质粒 ,并且能够刺激机体产生保护性免疫应答。
A pair of primers specific for hemagglutinin (HA) gene of H5 subtype Avian influenza virus (AIV) were designed according to published sequences. The HA gene was amplified by reverse transcription-polymerase chain reaction (RT-PCR) from a H5 subtype AIV strain G5 isolated from goose. The RT-PCR product was recovered and sequenced, and then inserted into eukaryotic expression vector pVAX1 and asd-pVAX1. The recombinant plasmid pVAX1-HA and asd-pVAX1-HA were transfected into mouse mastocytoma P815 cells. It was shown that transfected P815 cells transiently expressed the HA gene in indirect immunofluorescent assay. Furthermore, the recombinant pVAX1-HA and asd-pVAX1-HA were transformed into an attenuated S.typhimurium strain X4550, the transformants were screened, identified and named as X4550(pVAX1-HA) and X4550(asd-pVAX1-HA), respectively. After administered into BALB/c mice orally, both X4550(pVAX1-HA) and X4550(asd-pVAX1-HA) induced HA-specific serum antibodies, and supplied effective protection against the challenge of transfected P815 cells stably expressing HA gene of AIV H5 subtype. These results demonstrated that two Salmonella-based delivering systems can release harboured DNA vaccines in vivo, and elicit protective immune responses.
出处
《微生物学报》
CAS
CSCD
北大核心
2004年第2期157-161,共5页
Acta Microbiologica Sinica
基金
国家"8 63计划"( 2 0 0 2AA2 45 0 5 1)
国家自然科学基金资助项目 ( 3 0 170 70 0 )
江苏省高校自然科学研究计划项目 (J0 2 0 90 78)~~